Global Plant-Based Vaccines Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2020 – 2030

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Plant-Based Vaccines Market Year-on-Year Growth, 2021 - 2030 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Plant-Based Vaccines Market by Plant Type: Market Size and Forecast, 2020 – 2030

4.1    Overview

4.2  Potato

4.2.1  Current Trend and Analysis

4.2.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.2.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.3  Tobacco

4.3.1  Current Trend and Analysis

4.3.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.3.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.4  Maize

4.4.1  Current Trend and Analysis

4.4.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.4.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.5  Corn

4.5.1  Current Trend and Analysis

4.5.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.5.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.6  Others

4.6.1  Current Trend and Analysis

4.6.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.6.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 5        Global Plant-Based Vaccines Market by Vaccine Type: Market Size and Forecast, 2020 – 2030

5.1  Overview

5.2  Viral Vaccine

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.3  Bacterial Vaccine

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.4  Others

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 6        Global Plant-Based Vaccines Market by Application: Market Size and Forecast, 2020 – 2030 

6.1  Overview

6.2  Infectious Agents

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

6.3  Autoimmune Disorders

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

6.4  Anti-Cancer

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

6.5  Others

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast, 2020 - 2030 ($ Million)

6.5.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million) 

Chapter 7        Global Plant-Based Vaccines Market by Geography: Market Size and Forecast, 2020 – 2030

7.1  Overview

7.1.1   Global Plant-Based Vaccines Market Year-on-Year Growth, by region 2021 – 2030 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.3.2        By Plant Type

7.2.3.3        By Vaccine Type

7.2.3.4        By Application

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.4.2        By Plant Type

7.2.4.3        By Vaccine Type

7.2.4.4        By Application

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.5.2        By Plant Type

7.2.5.3        By Vaccine Type

7.2.5.4        By Application

7.2.6   Rest of North America

7.2.6.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.2.6.2        By Plant Type

7.2.6.3        By Vaccine Type

7.2.6.4        By Application

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.3.2        By Plant Type

7.3.3.3        By Vaccine Type

7.3.3.4        By Application

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.4.2        By Plant Type

7.3.4.3        By Vaccine Type

7.3.4.4        By Application

7.3.5   France

7.3.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.5.2        By Plant Type

7.3.5.3        By Vaccine Type

7.3.5.4        By Application

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.6.2        By Plant Type

7.3.6.3        By Vaccine Type

7.3.6.4        By Application

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.7.2        By Plant Type

7.3.7.3        By Vaccine Type

7.3.7.4        By Application

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.3.8.2        By Plant Type

7.3.8.3        By Vaccine Type

7.3.8.4        By Application

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.3.2        By Plant Type

7.4.3.3        By Vaccine Type

7.4.3.4        By Application

7.4.4   India

7.4.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.4.2        By Plant Type

7.4.4.3        By Vaccine Type

7.4.4.4        By Application

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.5.2        By Plant Type

7.4.5.3        By Vaccine Type

7.4.5.4        By Application

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.4.6.2        By Plant Type

7.4.6.3        By Vaccine Type

7.4.6.4        By Application

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast

7.5.3   South America

7.5.3.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.3.2        By Plant Type

7.5.3.3        By Vaccine Type

7.5.3.4        By Application

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.4.2        By Plant Type

7.5.4.3        By Vaccine Type

7.5.4.4        By Application

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2020 - 2030 ($ Million)

7.5.5.2        By Plant Type

7.5.5.3        By Vaccine Type

7.5.5.4        By Application

Chapter 8        Company Profiles

8.1  Medicago Inc.

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Fraunhofer Center for Manufacturing Innovation

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  EEA Consulting Engineers

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  Kentucky BioProcessing Inc.

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  Creative Biolabs

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  iBio

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  ICON

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Protalix

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

Back to top

Payment Options

Single User $5295
Five User $6195
Enterprise $8199
Datapack $2199
Short Report: $3099